Detalhe da pesquisa
1.
Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients.
J Viral Hepat
; 29(9): 765-776, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718996
2.
PEGylated NALC-functionalized gold nanoparticles for colorimetric discrimination of chiral tyrosine.
Analyst
; 145(22): 7397-7405, 2020 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935670
3.
[Efficacy of combination antiviral therapy following childbirth in pregnant HBV carriers receiving telbivudine for prevention of mother-to-child transmission].
Zhonghua Gan Zang Bing Za Zhi
; 23(11): 821-5, 2015 Nov.
Artigo
em Zh
| MEDLINE | ID: mdl-26743241
4.
Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C.
Scand J Infect Dis
; 45(12): 939-43, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24090457
5.
[Efficacy and safety of peginterferon alfa-2a (40 kd) plus adefovir for 96 weeks in HBeAg-negative chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 21(7): 498-501, 2013 Jul.
Artigo
em Zh
| MEDLINE | ID: mdl-24074706
6.
[Changes in lymphocyte surface expression of CD8 and CD38 molecules in peripheral blood of inactive HBsAg carriers following pegylated interferon a-2a therapy].
Zhonghua Gan Zang Bing Za Zhi
; 21(12): 895-8, 2013 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-24636289
7.
[Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin].
Zhonghua Gan Zang Bing Za Zhi
; 20(3): 216-20, 2012 Mar.
Artigo
em Zh
| MEDLINE | ID: mdl-22475143
8.
Sensitive colorimetric detection of melamine in processed raw milk using asymmetrically PEGylated gold nanoparticles.
Talanta
; 194: 475-484, 2019 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30609561
9.
[Factors associated with HBeAg seroconversion in chronic hepatitis B patients treated with interferon alfa-2a].
Zhonghua Gan Zang Bing Za Zhi
; 15(7): 481-4, 2007 Jul.
Artigo
em Zh
| MEDLINE | ID: mdl-17669233
10.
[The study of optimal treatment in patients with refractory chronic hepatitis C].
Zhonghua Gan Zang Bing Za Zhi
; 17(7): 488-9, 2009 Jul.
Artigo
em Zh
| MEDLINE | ID: mdl-19912679
11.
Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion.
J Dig Dis
; 14(8): 446-50, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23615131
12.
[Efficacy, influencing factors and safety of PEG-INF alpha-2a (PEG-INF-2a) in the treatment of chronic hepatitis C: analysis of 89 patients].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
; 20(2): 42-5, 2006 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-16816861